IBT
NKTX icon

International Biotechnology Trust’s Nkarta NKTX Stock Holding History

International Biotechnology Trust’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,034
Closed -$209K – 79
2022
Q1 		$209K Sell
10,034
-30,166
-75% -$323K 0.05% 69
2021
Q4 		$617K Sell
40,200
-16,245
-29% -$279K 0.14% 66
2021
Q3 		$1.57M Sell
56,445
-13,555
-19% -$429K 0.38% 46
2021
Q2 		$2.21M Buy
+70,000
New +$2.02M 0.58% 38

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

International Biotechnology Trust's NKTX Position: Q2 2022 in Review

International Biotechnology Trust sold out of Nkarta (NKTX) in Q2 2022, closing a stake of 10,034 shares — an estimated $209K sold.

International Biotechnology Trust first reported a position in NKTX in Q2 2021 and held it in 4 quarters. The position peaked at $2.21M in Q2 2021. 115 funds tracked by Wall St. Rank hold NKTX as of Q2 2022.

  • International Biotechnology Trust reported no remaining Nkarta position as of Q2 2022 after selling out during the quarter.
  • International Biotechnology Trust sold 10,034 Nkarta shares in Q2 2022, an estimated $209K.
  • International Biotechnology Trust first reported a position in Nkarta in Q2 2021 and held it in 4 quarters.
  • International Biotechnology Trust's Nkarta position peaked at $2.21M in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Nkarta as of Q2 2022.

Based on International Biotechnology Trust's 13F filing for Q2 2022, filed 16 Aug 2022.